TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bafna Pharmaceuticals Limited ( (IN:BAFNAPH) ) has shared an announcement.
Bafna Pharmaceuticals Limited announced the retirement of Mr. Palamadai Krishnan Sundaresan as an Independent Director, effective June 24, 2025. This change also affects his roles as Chairman of the Audit Committee and Member of the Nomination & Remuneration Committee. The company has reconstituted these committees with new appointments, ensuring continued compliance with applicable laws. This transition reflects Bafna Pharmaceuticals’ adaptability and commitment to maintaining strong governance structures.
More about Bafna Pharmaceuticals Limited
Bafna Pharmaceuticals Limited is a company operating in the pharmaceutical industry, focusing on the manufacturing and distribution of pharmaceutical products. The company is based in Chennai, Tamil Nadu, India, and is known for its commitment to quality and compliance with industry regulations.
Average Trading Volume: 1,035
Current Market Cap: 1.75B INR
Find detailed analytics on BAFNAPH stock on TipRanks’ Stock Analysis page.